Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
Introduction: The antipsychotic drug clozapine remains underutilized partly because of the risk of life-threatening adverse effects, such as neutropenia. Therefore, an extensive hematological monitoring program was set up to detect neutropenia. Methods: In this retrospective cohort study, we used re...
Saved in:
Main Authors: | Claas-Frederik Johannsen (Author), Tonny Studsgaard Petersen (Author), Jimmi Nielsen (Author), Anders Jørgensen (Author), Espen Jimenez-Solem (Author), Anders Fink-Jensen (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clozapine discontinuation withdrawal symptoms in schizophrenia
by: Graham Blackman, et al.
Published: (2021) -
Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review
by: Marcin Siwek, et al.
Published: (2024) -
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
by: Shusuke Numata, et al.
Published: (2018) -
Clozapine clinical toolkit optimizes inpatient clozapine monitoring
by: Brooke Gessner, PharmD, ACPR, et al.
Published: (2024) -
Clozapine‐associated severe eosinophilia following lithium rebound neutropenia: A case report
by: Kota Kikuchi, et al.
Published: (2020)